Lemon Bottle 10mg
For in-vitro laboratory research only. Not for human or animal administration.
Batch #: VPLM10100
Get Notified When Available
This product is currently out of stock. Enter your email and we'll notify you the moment it's back.
Research Use Only
For in-vitro laboratory research by qualified professionals only. Not for human or animal administration. Not a drug, food, cosmetic or dietary supplement. Not intended to diagnose, treat, cure, mitigate or prevent any disease. Batch-specific Certificates of Analysis available for all products.
Lemon Bottle 10mg: overview
What the vial contains and what the material is, stated as specifications rather than as outcomes.
Lemon Bottle supplied as a lyophilized powder in a sealed single-use vial containing 10 mg of material. Released to a specification of >99% purity by HPLC. Soluble in bacteriostatic water. Supplied for in-vitro laboratory research only. Not a drug, food or supplement. Not for human or veterinary use.
Volta does not provide dosing, administration or protocol guidance for any material listed.
Lemon Bottle 10mg specifications
Every field the product record holds. A field with no value is omitted rather than printed as a dash.
- Fill
- 10mg
- Form
- Lyophilized powder
- CAS number
- Custom Blend
- Molecular formula
- Custom Blend
- Solubility
- Soluble in bacteriostatic water
- Shelf life
- 24 months from date of manufacture
Lemon Bottle analytical verification and batch documentation
What the purity figure on this page is, who measured what, and which of the two a reader is looking at.
Specification. Every batch is released to >99% purity by HPLC. That is a threshold Volta sets, and it is a promise rather than a measurement.
Measurement. No certificate for this compound is published on the site yet. A batch-specific Certificate of Analysis is available on request, and the batch history lists the ones already published. Until one is published for this material, the figure above is the release specification and nothing on this page is a laboratory result.
Checking a certificate. The batch number printed beside the price is derived from the compound code and the vial strength; the lot number on a certificate is transcribed from the document. They are produced independently, so comparing them is a real check. How to read one is set out in the quality and testing methodology page.
For in-vitro laboratory research by qualified professionals only. Not for human or animal administration. Not a drug, food, cosmetic or dietary supplement. Not intended to diagnose, treat, cure, mitigate or prevent any disease.
This preparation is studied for adipocyte membrane effects through a different route than the deoxycholate-based solutions that preceded it. Lecithin acts as a phospholipid emulsifier, bromelain contributes proteolytic activity, and riboflavin serves as a flavin cofactor. The published mechanistic literature is thin relative to the compound's visibility, and it is a multi-component preparation rather than a defined molecule, so no CAS number applies. Supplied strictly as a laboratory research material.
- Released to a >99% purity specification by HPLC
- Lyophilized powder, 10mg per vial
- Soluble in bacteriostatic water
- For laboratory research use only
Frequently Bought Together
Lemon Bottle 10mg
10mg
$49 USD
Bundle & Save
$88 USD
Save $4.40 USD
$120 USD
Save $12 USD
$179 USD
Save $26.85 USD
$214 USD
Save $42.80 USD
Click any product above to toggle selection
Related research materials
Lemon Bottle 10mg: what is in the vial
The arithmetic specific to this 10mg vial, and what a milligram of Lemon Bottle costs in each strength the catalogue carries. Concentrations are stated, not recommended.
Vial contents
10 mg
Lyophilised powder, reconstituted by the buyer
Cost of material
$4.90 / mg USD
CA$7 / mg in Canadian dollars
Concentration at each diluent volume
10 mg of dry material reaches these concentrations in the volumes below. A U-100 syringe marking is 0.01 ml by definition, so the last column is a unit conversion at each concentration rather than a quantity to use.
| Diluent added | Concentration | In 0.1 ml | Per U-100 unit |
|---|---|---|---|
| 1 ml | 10 mg/ml | 1 mg | 100 mcg |
| 2 ml | 5 mg/ml | 500 mcg | 50 mcg |
| 3 ml | 3.33 mg/ml | 333.3 mcg | 33.3 mcg |
| 5 ml | 2 mg/ml | 200 mcg | 20 mcg |
For a volume this table does not list, the reconstitution calculator takes any vial size and diluent volume.
Lemon Bottle purity and identity: how the figure is measured
What >99% (HPLC) means, the masses an identity check has to land on, and the entries that make a certificate of analysis checkable rather than decorative.
Stated purity
>99% (HPLC)
Area percent of the main peak by reversed-phase HPLC
What a certificate for Lemon Bottle should carry
A purity percentage on its own is not checkable. These are the entries that make one verifiable, and their absence is the most common weakness in a research-peptide certificate.
The chromatogram, not only the number
A stated area percent with no trace behind it cannot be read for the shape of the main peak or for what eluted beside it. The HPLC interpreter walks through what a trace shows.
Net peptide content, separately from gross mass
A lyophilised peptide is a salt, usually of trifluoroacetic or acetic acid, plus residual water. The vial's stated milligrams are gross; net peptide content is the fraction of that mass which is the molecule. The two differ by ten to twenty percent routinely, and only one of them is what the price is per milligram of. The net peptide content calculator converts between them.
The counterion, named
Which salt form the powder is in changes the net content and the pH the powder dissolves at. A certificate that never names it leaves both unknowable.
Water content, by a stated method
Loss on drying and Karl Fischer titration give different numbers, and a water figure with no method attached cannot be compared with anyone else's.
A laboratory and a report identifier
Without both, nothing on the document can be traced back to the laboratory that issued it. The red flag checker lists the rest.
Batch certificates are published as page images in the certificate library. The source PDFs are never served: a certificate is the most forgeable document a supplier publishes, and an editable copy carrying an accredited laboratory's letterhead is worth more to a counterfeiter than to a customer.
Lemon Bottle storage and stability
Handling as the product record states it, followed by the degradation chemistry this particular sequence is and is not exposed to.
Handling
Store lyophilized peptide at -20°C in a dry, dark environment. Reconstitute in bacteriostatic water. Once reconstituted, store at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles. Lyophilized powder is stable at room temperature for shipping and short-term storage.
A residue-level stability profile needs a primary sequence of standard amino acids. This compound's sequence carries modified or non-standard residues, so no finding is derived for it rather than one being estimated from a partial reading. The storage guide covers the general case.
Lemon Bottle compared with GHK-Cu and Melanotan II
Pharmacological class, half-life, evidence grade, competition status and cost per milligram, side by side.
| Compound | Class | Half-life | Evidence | WADA | Cheapest per mg |
|---|---|---|---|---|---|
| GHK-Cu | Skin & Tissue Repair | ~30 minutes plasma | FNo Regulatory Activity | Not listed | $0.59100mg vial |
| Melanotan II | Melanocortin Agonist | ~36 minutes IV; longer SC due to depot effect | FNo Regulatory Activity | Prohibited | $3.2010mg vial |
| AHK-Cu (Copper AHK) | Cosmetic / Research | Not established | DPreclinical Only | Not listed | $0.64100mg vial, out of stock |
| Snap-8 | Cosmetic Peptide | Not established | FNo Regulatory Activity | Not listed | $3.2010mg vial, out of stock |
Evidence grades and half-lives are as recorded in the compound database, which cites its own sources on each compound page. Per-milligram prices are the cheapest strength each compound is currently listed at, in US dollars, and an out-of-stock note means that figure is not purchasable today. Cross-trial comparisons of efficacy are not comparisons: no head-to-head trial exists for most of these pairs.
Lemon Bottle in Canada
Price in Canadian dollars, where the parcel ships from, and how long it takes.
Price in CAD
CA$70
The figure charged, not a converted estimate
Ships from
British Columbia
A domestic parcel, so no import clearance step
Transit
2 to 5 business days
After 1 to 2 business days of handling
Free standard shipping
Over CA$250
A bar set for this market, not converted from the US one
Lemon Bottle 10mg ships from British Columbia to Canadian addresses, so the parcel never crosses a border. That removes the failure a Canadian buyer of research peptides is usually weighing: an inbound international shipment can be held for import clearance or seized, and a domestic one has no clearance step to be held at.
Shipping is quoted live against the delivery address at checkout rather than estimated here, and both the standard and express tiers show their price and transit window before a payment method is chosen. The figure the page shows is the figure the rail charges: all three settlement rails price shipping through the same functions the quote does.
The Canadian figure above is not a loose conversion. Each product's US dollar base is chosen so that the live conversion lands on the Canadian shelf price set for this market, and the result is pushed up to a whole dollar rather than left carrying cents, so one figure serves the page, the feed and every payment rail. See the shipping policy for carriers and cut-off times, and the legal position on research peptides in Canada for the regulatory picture.
Lemon Bottle Mechanism of Action
Lemon Bottle is a compounded solution described as combining riboflavin, bromelain and lecithin, positioned as a non-deoxycholate alternative for injectable lipolysis. No quantity is stated for any constituent, which is the first thing to note, because in a preparation whose identity is a ratio of three ingredients an undisclosed formula means the product is not specified at all.
The three constituents have no shared mechanism. Riboflavin is vitamin B2, the precursor of the flavin cofactors FAD and FMN that carry electrons in numerous redox enzymes, and its deficiency literature concerns metabolic disorders rather than adipose tissue. Bromelain is a mixture of proteolytic enzymes from pineapple, studied for digestion, inflammation and enzymatic debridement of burns. Lecithin is a phosphatidylcholine-containing material, and it is the only one of the three with any connection to the injectable lipolysis field.
That connection is worth taking seriously because it is the closest thing to a mechanistic rationale here. Injectable phosphatidylcholine has been studied for localised fat reduction, and a phase II trial of a soybean phosphatidylcholine preparation has been published. The mechanism proposed in that field is disruption of adipocyte membranes rather than any metabolic effect, which is a detergent-like action rather than a nutritional one.
Riboflavin as a flavin precursor
Vitamin B2 is the precursor of FAD and FMN, cofactors in redox enzymes. Its established literature concerns deficiency states and metabolic disorders, not adipose tissue.
Bromelain as a proteolytic mixture
A mixture of cysteine proteases from pineapple, with published work in digestion, inflammation and enzymatic debridement of burn eschar.
Lecithin and phosphatidylcholine
The only constituent connected to injectable lipolysis. Phosphatidylcholine preparations have been studied for localised fat reduction, with a published phase II trial of a soybean-derived formulation.
Proposed membrane disruption
In the injectable lipolysis field the proposed action is disruption of adipocyte membranes, a detergent-like effect rather than a metabolic one.
No combined mechanism published
Nothing explains what the three together are supposed to do, and no quantity is disclosed for any of them, so the proposed action cannot be evaluated even in principle.
Constituent and Comparator Research Findings
No entry below used this product. Each concerns a single constituent or the injectable lipolysis field it positions itself within, and says which.
Bromelain's health effects reviewed critically
A critical review of the current literature assessed the potential health benefits of bromelain across its studied applications, which are largely digestive and anti-inflammatory rather than adipose.
ObservationalBromelain therapeutic potential and formulation reviewed
A review examined bromelain and its nanoformulations, covering how the enzyme mixture is delivered and stabilised, which is the practical obstacle to using a proteolytic enzyme therapeutically.
MechanisticCytotoxic, proapoptotic and genotoxic effects of bromelain assessed in human cells
An assessment of bromelain on human peripheral blood cells examined cytotoxicity, apoptosis and genotoxicity. This is included deliberately: a proteolytic enzyme injected into tissue is not self-evidently benign, and this is the kind of work that addresses it.
In vitroEnzymatic debridement of deep burns with a bromelain-based preparation
A review of enzymatic debridement described the clinical use of a bromelain-based agent to remove burn eschar. It demonstrates that the enzyme is active on tissue in vivo, which is relevant context for injecting it.
ObservationalPhase II trial of an injectable soybean phosphatidylcholine preparation
A randomised, double-blind, placebo-controlled phase II trial evaluated a soybean phosphatidylcholine formulation for localised fat reduction. This is the closest published evidence to the lecithin constituent and it used a defined, quantified preparation.
Phase 2 trialSerious adverse events after injectable deoxycholic acid documented
A paper on management of serious adverse events following deoxycholic acid injection for submental and jowl treatment records what goes wrong with an approved injectable lipolytic agent under medical supervision.
ObservationalPeripheral nerve injury after deoxycholic acid injection in an experimental model
Work in a rat model characterised peripheral nerve injury following deoxycholic acid injection, establishing a mechanism for one of the adverse effects reported clinically with the approved agent.
Rodent modelRiboflavin responsiveness in metabolic disorders
A systematic review of riboflavin therapy in complex I deficiency and related leukoencephalopathy describes where this vitamin has established therapeutic use, which is in inherited metabolic disease rather than in adipose tissue.
ObservationalLemon Bottle Composition
| Product Type | Compounded multi-constituent solution, not a peptide |
| Stated Constituents | Riboflavin, bromelain and lecithin |
| Constituent Quantities | Not disclosed for any of the three |
| Riboflavin | Vitamin B2, precursor of the flavin cofactors FAD and FMN |
| Bromelain | A mixture of cysteine proteases from pineapple, not a single enzyme |
| Lecithin | A phosphatidylcholine-containing material, source and grade unstated |
| CAS Number | Not applicable. A mixture has no single CAS number |
| Positioning | Described as a non-deoxycholate alternative preparation |
| Regulatory Status | Not approved as a medicine in any jurisdiction |
| Appearance | Yellow solution, the colour attributable to riboflavin |
Undisclosed Quantities Mean the Product Is Not Specified
For most products in this catalogue the open question is whether the stated molecule is present at the stated purity. Here there is no stated quantity for any of the three constituents, which is a more fundamental gap.
A three-component solution is defined by its ratio. Without one, two preparations bearing this name could differ by orders of magnitude in any constituent and both would match the description. Nothing on a certificate could establish that a given vial matches any other vial, because there is no specification to match against.
That also makes the safety literature uninterpretable in either direction. Bromelain is a proteolytic enzyme used clinically to debride burn eschar, which is to say it digests tissue. How much of it is present is not a detail.
The Comparator Has Trials and a Documented Harm Profile
This product is positioned as a non-deoxycholate alternative, which invites comparison with deoxycholic acid, the approved injectable lipolytic. That comparison is worth making properly, because the approved agent is informative in two directions.
It has controlled trials establishing efficacy, and it has a published adverse event literature: management papers on serious adverse events following injection, and experimental work characterising peripheral nerve injury in a rat model. Those harms occurred with a defined, quantified agent administered under medical supervision.
Being an alternative to deoxycholate says nothing about being safer than it. An agent with no trials has no demonstrated efficacy, and an agent with no published safety reporting has no demonstrated safety either, only an absence of data. Those are different from a favourable record, and the distinction is the whole of what can be said here.
One Constituent Has a Rationale, Two Do Not
Lecithin is the only constituent with any published connection to localised fat reduction. Injectable phosphatidylcholine has been studied in the field, and the phase II trial cited here evaluated a soybean phosphatidylcholine formulation in a randomised, placebo-controlled design. That is real evidence about a related material, though not about this one.
Riboflavin's established therapeutic use is in inherited metabolic disease, particularly riboflavin-responsive disorders of acyl-CoA dehydrogenation and complex I deficiency. Nothing in that literature concerns adipose tissue, and its most visible contribution to this product is the yellow colour.
Bromelain's published applications are digestive, anti-inflammatory and debridement. None involves fat reduction. Its inclusion is unexplained by any published mechanism, and the work assessing its cytotoxic and genotoxic effects on human cells is the relevant literature for putting it into tissue.
Handling and Analytical Considerations
The three constituents could hardly be more different analytically. Riboflavin is a small, intensely coloured, strongly light-sensitive molecule that is straightforward to quantify by ultraviolet-visible absorbance. Lecithin is a lipid mixture requiring entirely different chromatography. Bromelain is not a single molecule at all but a mixture of proteases, so its content is properly expressed as enzymatic activity rather than as mass.
That last point matters. A protease preparation is characterised by activity units, because the same mass of partially denatured enzyme has less. A certificate reporting a bromelain mass without an activity assay has not established that the enzyme is active, and riboflavin's light sensitivity means the whole solution needs protection from light regardless of what the other two require.
Lemon Bottle Research FAQ
Lemon Bottle in Summary
Lemon Bottle is a compounded solution of riboflavin, bromelain and lecithin with no disclosed quantities, positioned as a non-deoxycholate injectable lipolytic. Only lecithin has any published connection to the field it is sold into.
No study has examined the product. The approved comparator, deoxycholic acid, has both controlled trials and a documented adverse event literature including nerve injury, and being an alternative to it establishes neither efficacy nor safety.
Scientific References
Primary literature and public trial registries only. No supplier or retailer pages are cited.
No published study has examined this product. Searching PubMed for the brand name returns nothing: no trial, no pharmacology, no safety report, no analytical characterisation. The references below cover two things that can honestly be cited: the individual constituents riboflavin and bromelain, studied in unrelated contexts, and the injectable lipolysis field this product positions itself within, where the comparator agents do have controlled trials and a documented adverse event literature. None of them used this preparation, and the constituent quantities are not disclosed anywhere.
- 1Potential health benefits of bromelain: a critical review of the current literatureSanlier N, Irmak E, et al. · Frontiers in Nutrition · 2026
- 2Harnessing therapeutic potential of bromelain and its nanoformulationsRavindra RR, Kaur J, et al. · Daru Journal of Pharmaceutical Sciences · 2025
- 3Assessment of the cytotoxic, proapoptotic, and genotoxic effects of bromelain on human peripheral blood cellsBernasinska-Slomczewska J, Hikisz P, et al. · Scientific Reports · 2026
- 4Enzymatic Debridement of Deep BurnsYaron Y, Krieger Y, et al. · Harefuah · 2025
- 5Randomized, Double-Blind, Placebo-Controlled Phase II Trial of AYP-101 (Soybean Phosphatidylcholine)Choi SY, Abd El-Aty AM, et al. · Clinical Therapeutics · 2025
- 6Management of Serious Adverse Events Following Deoxycholic Acid Injection for Submental and Jowl TreatmentShridharani SM, Kennedy ML, et al. · Aesthetic Surgery Journal Open Forum · 2024
- 7Peripheral Nerve Injury After Deoxycholic Acid (ATX-101) Injection in an Experimental Rat ModelChi D, Pinni S, et al. · Aesthetic Surgery Journal · 2025
- 8Riboflavin therapy in complex I deficiency: Two new cases of leukoencephalopathy and a systematic reviewFerrera G, Invernizzi F, et al. · Journal of the Neurological Sciences · 2026
Disclaimer
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are furnished for in-vitro studies only. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease.
Lemon Bottle 10mg: frequently asked questions
Answered from the product record and the certificate file. Volta does not answer questions about administration, dosing or protocols.
What is supplied in a 10 mg vial of Lemon Bottle?
A sealed single-use vial containing 10 mg of Lemon Bottle as a lyophilized powder. Soluble in bacteriostatic water. No diluent, syringe or other supply is included.
Is Lemon Bottle supplied for human use?
No. For in-vitro laboratory research by qualified professionals only. Not for human or animal administration. Not a drug, food, cosmetic or dietary supplement. Not intended to diagnose, treat, cure, mitigate or prevent any disease. Volta does not provide dosing, administration or protocol guidance for any material listed.
What purity is this Lemon Bottle released to?
>99% by HPLC. That figure is a release specification, a threshold Volta sets for every batch, and it is not the same kind of statement as a purity measured by a named laboratory for a named lot.
Is there a certificate of analysis for this Lemon Bottle vial?
A batch-specific Certificate of Analysis is available for this product on request. It is not published on the site yet: the batch history on the quality page lists the certificates already published, and this vial is covered by the release specification until its own is added there.
How should Lemon Bottle be stored before reconstitution?
Store lyophilized peptide at -20°C in a dry, dark environment. Reconstitute in bacteriostatic water. Once reconstituted, store at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles. Lyophilized powder is stable at room temperature for shipping and short-term storage.
Where does this ship from?
British Columbia, Canada. Canadian orders are domestic, so they clear no customs and pay no import duty. International orders ship from the same facility.
Related Research News
Oxytocin's Vital Role in Social and Relationship Bonds
Oxytocin, known as the love hormone, supports social connections through release during touch, trust, and intimacy. Research indicates it aids trust, empathy, and bonding in romantic, parental, and friendly relationships, though effects depend on context and individual factors. This peptide also interacts with stress systems to promote emotional regulation and well-being.
Atosiban Serves as Maintenance Therapy for Preterm Labor
Atosiban, an oxytocin-receptor antagonist marketed in China in 2006, offers maintenance treatment to manage preterm labor risks after initial tocolysis. Clinical trials show it delays delivery better than placebo in some cases and has fewer side effects than beta-2 agonists. Studies highlight its safety and role in reducing recurrent preterm labor episodes.
Explore Research
Peptide Tools
More from the research catalogue
Every compound below has its own specification, batch number and certificate page, whether or not a vial is in stock today. Supplied for laboratory research use only.
Related research compounds
- Melanotan I 10mgrestocking
- Melanotan II 10mg
- Snap-8 10mgrestocking
- AHK-Cu 100mgrestocking
- Super Human Blend (HB) 865mgrestocking